Literature DB >> 11118184

An integrated national pharmaceutical policy for the United Kingdom?

T Walley1, A Earl-Slater, A Haycox, A Bagust.   

Abstract

Mesh：

Year:  2000        PMID： 11118184      PMCID： PMC1119223          DOI： 10.1136/bmj.321.7275.1523

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Generic prescribing: time to regulate the market? Price rises are a blow to nascent primary care groups.

Authors:  T Walley; P Burrill
Journal:  BMJ       Date:  2000-01-15

2.  The importance of the pharmaceutical industry to the UK economy.

Authors:  A Earl-Slater
Journal:  J Manag Med       Date:  1998

3.  Puzzling out priorities. Why we must acknowledge that rationing is a political process.

Authors:  R Klein
Journal:  BMJ       Date:  1998-10-10

4.  Too soon to market.

Authors:  T H Dent; S Hawke
Journal:  BMJ       Date:  1997-11-15

5.  Regulating the price of the UK's drugs: second thoughts after the government's first report.

Authors:  A Earl-Slater
Journal:  BMJ       Date:  1997-02-01

6.  Ruling on interferon beta will hit all health authorities.

Authors:  C Dyer
Journal:  BMJ       Date:  1997-07-19

7.  Treatment for haemophilia by postcode.

Authors:  C A Ludlam; C R Hay; G Dolan
Journal:  BMJ       Date:  1997-03-08
  7 in total
  6 in total

Review 1.  From guidance to practice: Why NICE is not enough.

Authors:  Thomas H S Dent; Mike Sadler
Journal:  BMJ       Date:  2002-04-06

2.  Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country.

Authors:  Dragan R Milovanovic; Radomir Pavlovic; Miroslav Folic; Slobodan M Jankovic
Journal:  Eur J Clin Pharmacol       Date:  2004-04-01       Impact factor: 2.953

3.  An Australian perspective.

Authors:  Anthony J Smith
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

Review 4.  The concept of essential medicines: lessons for rich countries.

Authors:  Hans V Hogerzeil
Journal:  BMJ       Date:  2004-11-13

5.  European healthcare policies for controlling drug expenditure.

Authors:  Silvia M Ess; Sebastian Schneeweiss; Thomas D Szucs
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 6.  National medicines policies - a review of the evolution and development processes.

Authors:  Joëlle M Hoebert; Liset van Dijk; Aukje K Mantel-Teeuwisse; Hubert Gm Leufkens; Richard O Laing
Journal:  J Pharm Policy Pract       Date:  2013-07-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.